Fagron's competitors

Fagron's competitors include Haemonetics Corporation, Tristel, Adverse Health and Eisai
Add company...
Fagron
Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries worldwide.
Haemonetics Corporation
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Braintree, Massachusetts by Dr. Jack Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries.
Tristel
High-level infection control products for surfaces and instruments within human healthcare. Cost-effective, maximum efficacy and quick contact times!
Adverse Health
Advera Health is a healthcare informatics company that uses data-mining and analytics for comprehensive analysis of drug evidence.
Eisai
As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.
Founding Date
Founding Date
1990
Founding Date
1971
Founding Date
1998
Founding Date
2010
Founding Date
1941
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Rotterdam, NL HQ
Locations
Braintree, US HQ
Macquarie Park, AU
Edmonton, CA
Vancouver, CA
Shanghai, CN
Bengaluru, IN
Chiyoda, JP
see more
Locations
Snailwell, GB HQ
Locations
Santa Rosa, US HQ
Locations
Woodcliff Lake, US HQ
Employees
Employees
2,334
Employees
3,107 4% decrease
Employees
99 2% decrease
Employees
11 8% decrease
Employees
10,495
Valuation ($)
Valuation ($)
897 b
Valuation ($)
3.7 b
Valuation ($)
155 m
Valuation ($)
N/A
Valuation ($)
15.9 b
Facebook followers
Facebook followers
363
Facebook followers
240
Facebook followers
150
Facebook followers
223
Facebook followers
N/A
Twitter followers
Twitter followers
608
Twitter followers
251
Twitter followers
1
Twitter followers
1.5 k
Twitter followers
3.5 k

Financial

Net income
Net income
N/A
Net income
($26.3m) (FY, 2017)
Net income
£2.3m (FY, 2016)
Net income
N/A
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles